Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Synflorix Co-administered with Infanrix-Hexa in Preterm Infants
NCT00390910Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- Jul 2007
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Oct 2006; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00390910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390910.